Veru Inc. (NASDAQ:VERU) Stock Position Boosted by SG Americas Securities LLC

SG Americas Securities LLC grew its holdings in shares of Veru Inc. (NASDAQ:VERU) by 132.4% in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 153,656 shares of the company’s stock after purchasing an additional 87,528 shares during the period. SG Americas Securities LLC owned approximately 0.10% of Veru worth $100,000 as of its most recent filing with the Securities and Exchange Commission.

Several other large investors also recently made changes to their positions in the business. 180 Wealth Advisors LLC boosted its position in shares of Veru by 41.0% during the 4th quarter. 180 Wealth Advisors LLC now owns 293,350 shares of the company’s stock valued at $191,000 after purchasing an additional 85,350 shares in the last quarter. Weaver Consulting Group boosted its position in shares of Veru by 41.0% during the 4th quarter. Weaver Consulting Group now owns 69,705 shares of the company’s stock valued at $45,000 after purchasing an additional 20,280 shares in the last quarter. PVG Asset Management Corp boosted its position in shares of Veru by 13.1% during the 3rd quarter. PVG Asset Management Corp now owns 636,970 shares of the company’s stock valued at $490,000 after purchasing an additional 73,815 shares in the last quarter. Barclays PLC boosted its position in shares of Veru by 309.2% during the 3rd quarter. Barclays PLC now owns 184,777 shares of the company’s stock valued at $142,000 after purchasing an additional 139,617 shares in the last quarter. Finally, Geode Capital Management LLC boosted its position in shares of Veru by 4.7% during the 3rd quarter. Geode Capital Management LLC now owns 2,940,140 shares of the company’s stock valued at $2,261,000 after purchasing an additional 131,720 shares in the last quarter. Institutional investors own 47.16% of the company’s stock.

Veru Trading Up 4.6 %

VERU stock opened at $0.55 on Thursday. Veru Inc. has a one year low of $0.36 and a one year high of $1.92. The firm has a market capitalization of $80.51 million, a PE ratio of -1.96 and a beta of -0.54. The firm has a 50-day moving average of $0.72 and a two-hundred day moving average of $0.77.

Veru (NASDAQ:VERU) last posted its quarterly earnings data on Monday, December 16th. The company reported ($0.06) EPS for the quarter, beating analysts’ consensus estimates of ($0.07) by $0.01. Veru had a negative net margin of 223.85% and a negative return on equity of 92.88%. On average, equities research analysts anticipate that Veru Inc. will post -0.26 earnings per share for the current year.

Wall Street Analysts Forecast Growth

Several equities analysts have recently weighed in on VERU shares. HC Wainwright restated a “buy” rating and set a $3.00 price objective on shares of Veru in a research report on Thursday, January 2nd. Oppenheimer reaffirmed an “outperform” rating and set a $5.00 price objective on shares of Veru in a research note on Tuesday, November 5th.

About Veru

Veru Inc, a late clinical stage biopharmaceutical company, focuses on developing medicines for treatment of metabolic diseases, oncology, and acute respiratory distress syndrome (ARDS). Its marketed products comprise FC2 female condom for the dual protection against unplanned pregnancy and the transmission of sexually transmitted infections.